Overall Technical outlook

Price Summary

On 2026-04-09, CONCORDBIO's stock opened at 1058.2, reached a peak of 1094.2, dropped to 1046.4, and ended -0.33% down at 1054.7, with a volume of 240409 shares.
The stock's peak price over the last 52 weeks is 2130.4, with the lowest being 0.0.
The projected price range for Concord Biotech Limited is between 1170.0 and 1680.0, with an expected mean price of 1426.6666, according to 6 analysts.

Technicals


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for CONCORDBIO. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
CONCORDBIO aroon 8db8d3
Aroon chart for Concord Biotech Limited


Bol. Bands: The current state of the BOLL BANDS is neutral for CONCORDBIO, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
CONCORDBIO bbands 8db8d3
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR for CONCORDBIO maintains a bullish outlook, establishing a crucial support level that may help maintain the current upward momentum. This strong support suggests that the market is poised to continue its upward trend, providing confidence in the ongoing bullish sentiment.
CONCORDBIO psar 8db8d3
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The current reading of the STOCHASTIC is neutral for CONCORDBIO, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
CONCORDBIO stoch 8db8d3
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The 20-50-100 period moving averages suggest a bullish trend, though the weakening slopes of the shorter-term averages raise concerns about a potential reversal. While the overall momentum is still upward, the indications from the faster averages suggest that the trend might be nearing its end, warranting caution.
CONCORDBIO trippleSMA 8db8d3
Tripple SMA chart for Concord Biotech Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.